Redwood Ai Corp. · CSE:AIRX
Redwood Ai — Investor Presentation (June 2026)
24 slides from Redwood Ai's investor presentation, Jun 8, 2026
Slide 1: Redwood AI: AI platform for chemical synthesis, drug discovery, and defense
CSE: AIRX Redwood Al AI platform for chemical synthesis, drug discovery, and defense applications June 2026
Slide 2: Disclaimer
DISCLAIMER Disclaimer Disclaimer Forward-Looking Information This presentation may contain “forward-looking information” within the meaning of applicable Canadian securities legislation (“forward-looking statements”) with respect to Redwood AI Corp. (the “Company”). All information, other than state
Slide 3: What Is Redwood AI?
WHAT IS REDWOOD AI? Redwood AI is an AI-powered chemistry platform that helps discover new medicines, design chemical processes, and analyze chemical data across drug discovery, advanced materials, and defense applications. The platform supports applications across scientific and strategic sectors i
Slide 4: What Can Redwood AI's Platform Do?
WHAT CAN REDWOOD AI’S PLATFORM DO? Predict how complex chemicals can be produced Design and optimize new molecules Analyze large chemical datasets Identify efficient and scalable chemical manufacturing processes
Slide 5: Industries Served by the Platform
INDUSTRIES SERVED BY THE PLATFORM Drug Discovery Redwood AI’s platform can accelerate discovery of new medicines, design new molecules, and support future AI-driven drug candidate generation. Defense and National Security Redwood AI’s platform can analyze chemical data to identify potential threats
Slide 6: Why These Industries Need AI Platforms
WHY THESE INDUSTRIES NEED AI PLATFORMS Chemical Complexity Is Increasing Modern drugs, materials, and chemical products are becoming more complex to design and manufacture.¹ Chemical Data Is Growing Rapidly Large volumes of experimental and synthesis data require advanced tools to analyze and extrac
Slide 7: Strategic Application Areas
STRATEGIC APPLICATION AREAS Drug Discovery & Therapeutics AI-driven analysis of chemical datasets to accelerate drug discovery and support future candidate generation. Example: Identify promising drug candidates earlier in the discovery process. Defense & Strategic Applications Chemical capabilities
Slide 8: Market Opportunity
MARKET OPPORTUNITY Redwood’s AI-powered chemistry platform operates across pharmaceutical development, AI- Global Pharmaceutical Market Size driven discovery, and emerging chemical 2020 to 2030 (USD Trillion) intelligence applications. Embedded within the $1.65T USD (2024) global pharmaceutical mark
Slide 9: AI and Chemical Intelligence in Defense Applications
AI AND CHEMICAL INTELLIGENCE IN DEFENSE APPLICATIONS AI adoption across defense and national security systems is accelerating, increasing demand for advanced analytics and chemical intelligence capabilities. Global Defence Spending Market Market Growth 2024 to 2035 (USD Trillion) The global defense
Slide 10: AI Acceleration in the Global CDMO Market
AI ACCELERATION IN THE GLOBAL CDMO MARKET AI adoption in drug manufacturing and development is accelerating, creating a structural opportunity within the global CDMO market. Pharmaceutical CDMO Market Size 2025 to 2034 (USD Billion) Market Growth The global CDMO market is projected to grow from $197
Slide 11: AI in Drug Discovery and Molecular Design
AI IN DRUG DISCOVERY AND MOLECULAR DESIGN AI adoption is accelerating in early discovery, molecular design, and candidate prioritization. Market Growth AI In Drug Discovery Market Size, by Application The global AI in drug discovery market is projected to 2025 to 2035 (USD Billion) grow from $6.9B U
Slide 12: Redwood AI Overview
REDWOOD AI OVERVIEW Building an AI-powered chemistry platform that predicts chemical synthesis pathways, optimizes manufacturing processes, and analyzes chemical datasets to support drug discovery, defense-related applications, and industrial chemistry. Our Technology Redwood AI is building a propri
Slide 13: Redwood AI Technology Platform
REDWOOD AI TECHNOLOGY PLATFORM Synthesis Intelligence Models trained on billions of reactions predict efficient synthesis routes. Process Optimization Optimization algorithms identify reaction conditions that improve yield, purity, and efficiency. Chemical Safety & Hazard Analysis Analyzes chemical
Slide 14: Existing Technology – Scale and Accuracy
EXISTING TECHNOLOGY – SCALE AND ACCURACY Manual Process • Manual review cannot be scaled. Conventional • Operational costs for multi-chemist review means either long turnaround times or high project costs. Target molecule must Target molecule be manually reviewed, for analysis • Fewer options and co
Slide 15: Redwood AI Platform Roadmap
REDWOOD AI PLATFORM ROADMAP Strategic roadmap expanding Redwood’s AI-powered chemistry platform into molecular design, candidate generation, and strategic applications including defense. Today AI-powered platform for predicting and optimizing chemical synthesis across drug discovery, chemical manufa
Slide 16: Competitive Landscape: AI Chemistry and Synthesis Intelligence
COMPETITIVE LANDSCAPE: AI CHEMISTRY AND SYNTHESIS INTELLIGENCE Cost Synthesis Scale Safety Environment Company Included? Captured? Included? Included? Review? Redwood AI, 2026 + ++ + + + IBM RXN - + - - - Iktos Spaya + + - - - Merck Synthia + + - +/- +/- ChemAIRS - + + +/- - Sources: Company website
Slide 17: Comparable AI Platforms
COMPARABLE AI PLATFORMS Market Cap / Capital Company Focus Notes Raised (USD) AI driven generative drug discovery platform. Generative Drug $400M+ Raised Discovery AI designed candidates advanced to clinical trials. AI for drug discovery platform. $1.89B Market Cap AI Drug Discovery Publicly listed
Slide 18: Who We Are
WHO WE ARE Team • Two successful private company exits and multiple IPOs. Louis Dron, MSc CEO Kristian Thorlund, PhD President & Director Glenn Sammis, PhD Head of Chemistry Mark R. Dybul, MD Public Safety & Defense Advisor • Experience ranging from chemistry and data science to financing. Ofir Hara
Slide 19: Team
TEAM Louis Dron, MSc Kristian Thorlund, PhD Glenn Sammis, PhD Ofir Harari, PhD Prince Lat, PhD CEO President & Director Head of Chemistry Head of AI Senior Data Scientist Mr. Dron is a healthcare executive with Dr. Thorlund, with over 15 years of Dr. Sammis is a worldwide leader in Dr. Harari is a h
Slide 20: Team Cont'
TEAM CONT’ Nico Mah Sam Shahrokhi Graydon Bensler Masoud Darbandi Matthew Mingay CFO & Corporate Secretary Director Director Director Director Mr. Mah is a Chartered Professional Mr. Shahrokhi is an accomplished Mr. Bensler is a financial professional Mr. Darbandi is a sales strategist with Mr. Ming
Slide 21: Team Cont'
TEAM CONT’ Mark R. Dybul, MD Matthew A. Roberts, PhD Public Safety & Defense Advisor Public Safety & Defense Advisor Dr. Dybul is a physician, scientist, Over the course of his 25-year career, and internationally recognized public Dr. Roberts has held senior executive health leader with more than tw
Slide 22: Redwood AI Highlights
REDWOOD AI HIGHLIGHTS Expanding Market Opportunity Broad Applicability Across Scientific Embedded within the $1.65T (2024) global Markets pharmaceutical market, projected to exceed ~$2.35T by 2030¹ Applicable across pharmaceuticals, Operating within the $197.4B+ (2025) global CDMO biotechnology, ind
Slide 23: Capital Structure
CAPITAL STRUCTURE As of June 8, 2026 Common Shares Issued & Outstanding: 37,063,553 Warrants: 4,455,500 Issued & Outstanding Fully Diluted: 42,419,053
Slide 24: Contact
CSE: AIRX Redwood Al Contact Address: [email protected] 1309-7th Street SW Calgary, AB, T2R 1A5 www.redwoodai.com Canada